Pharmalot Pharmalot April 11, 2025 STAT Plus: FDA plans to phase out animal testing in drugs in what it calls a ‘paradigm shift’
Pharmalot Pharmalot April 11, 2025 STAT Plus: Pharmalittle: We’re reading about FDA drug reviews, Novartis investing $23 billion in the U.S., and more
Pharmalot Pharmalot April 10, 2025 STAT Plus: Arkansas may force companies to choose between running a PBM or pharmacies
Pharmalot Pharmalot April 10, 2025 STAT Plus: Pharmalittle: We’re reading about the FDA closing generic drug office, its U-turn on remote work, and more
Pharmalot Pharmalot April 10, 2025 STAT Plus: Gilead is urged to rework licensing deals for groundbreaking HIV prevention drug